Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CALL
Teva Pharmaceuticals
TEVA
$42.8B
| $16.7M | ﹤0.01% |
1,731,400
-66,200
| -4% | -$634K |
|
|
GRUB
1902
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $16.7M | ﹤0.01% |
112,400
-27,400
| -20% | -$4.05M |
|
1903
Invesco CurrencyShares Swiss Franc Trust
FXF
$395M
| $16.7M | ﹤0.01% |
161,817
+10,867
| +7% | +$1.1M |
|
1904
BridgeBio Pharma
BBIO
$15.6B
| $16.7M | ﹤0.01% |
234,283
+120,665
| +106% | +$5.82M |
|
1905
Madison Square Garden
MSGS
$9.8B
| $16.6M | ﹤0.01% |
90,436
-83,203
| -48% | -$13.7M |
|
1906
Sunstone Hotel Investors
SHO
$2.03B
| $16.6M | ﹤0.01% |
1,469,425
+1,431,749
| +3,800% | +$13.7M |
|
1907
PUT
KKR & Co
KKR
$102B
| $16.6M | ﹤0.01% |
411,000
-43,100
| -9% | -$1.63M |
|
1908
CALL
Lincoln National
LNC
$8.7B
| $16.6M | ﹤0.01% |
330,700
-6,800
| -2% | -$289K |
|
1909
Lockheed Martin
LMT
$140B
| $16.6M | ﹤0.01% |
46,777
+5,772
| +14% | +$2.12M |
|
1910
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $16.5M | ﹤0.01% |
498,842
+36,674
| +8% | +$1.18M |
|
1911
CALL
Devon Energy
DVN
$50.4B
| $16.5M | ﹤0.01% |
1,045,000
+580,200
| +125% | +$7.19M |
|
1912
CALL
JetBlue
JBLU
$2.13B
| $16.5M | ﹤0.01% |
1,134,600
+400,900
| +55% | +$5.5M |
|
1913
International Flavors & Fragrances
IFF
$21.5B
| $16.5M | ﹤0.01% |
151,531
-105,912
| -41% | -$11.9M |
|
|
1914
PUT
iShares Core S&P 500 ETF
IVV
$908B
| $16.5M | ﹤0.01% |
43,900
+1,700
| +4% | +$605K |
|
1915
PUT
Canadian Solar
CSIQ
$1.03B
| $16.5M | ﹤0.01% |
321,600
+94,900
| +42% | +$3.89M |
|
1916
PUT
ARK Web x.0 ETF
ARKW
$1.8B
| $16.5M | ﹤0.01% |
112,500
+107,200
| +2,023% | +$13.7M |
|
|
1917
PUT
JetBlue
JBLU
$2.13B
| $16.5M | ﹤0.01% |
1,131,400
+635,300
| +128% | +$8.72M |
|
|
BAND
1918
Bandwidth Inc
BAND
$1.74B
| $16.4M | ﹤0.01% |
106,658
+90,708
| +569% | +$15M |
|
1919
CALL
MarketAxess Holdings
MKTX
$5.72B
| $16.4M | ﹤0.01% |
28,700
-4,600
| -14% | -$2.51M |
|
1920
Ericsson
ERIC
$33.6B
| $16.4M | ﹤0.01% |
1,368,852
+1,124,560
| +460% | +$13.2M |
|
1921
iShares Russell 1000 Growth ETF
IWF
$128B
| $16.4M | ﹤0.01% |
271,228
+255,400
| +1,614% | +$14.5M |
|
|
KSU
1922
CALL
DELISTED
Kansas City Southern
KSU
| $16.4M | ﹤0.01% |
80,100
-136,500
| -63% | -$25.6M |
|
|
SGEN
1923
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $16.3M | ﹤0.01% |
93,300
+15,100
| +19% | +$2.82M |
|
1924
CALL
Emerson Electric
EMR
$91B
| $16.3M | ﹤0.01% |
203,300
-180,500
| -47% | -$13.4M |
|
|
GBT
1925
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $16.3M | ﹤0.01% |
377,245
-298,927
| -44% | -$14.7M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.